The pathogenesis and alternative treatment of SARS-CoV2.
作者信息
Choi Jun-Yong, Joo Myungsoo
机构信息
Department of Internal Medicine, Korean Medicine Hospital, Pusan National University, Yangsan 50612, Republic of Korea.
School of Korean Medicine, Pusan National University, Yangsan 50612, Republic of Korea.
出版信息
Integr Med Res. 2020 Sep;9(3):100421. doi: 10.1016/j.imr.2020.100421. Epub 2020 May 3.
Abstract
摘要
相似文献
1
The pathogenesis and alternative treatment of SARS-CoV2.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的发病机制及替代治疗方法
Integr Med Res. 2020 Sep;9(3):100421. doi: 10.1016/j.imr.2020.100421. Epub 2020 May 3.
2
Reactive Arthritis in a 37-Year-Old Female With SARS-CoV2 Infection.一名感染新型冠状病毒2的37岁女性的反应性关节炎
Cureus. 2020 Aug 12;12(8):e9698. doi: 10.7759/cureus.9698.
引用本文的文献
1
From SARS to SARS-CoV-2, insights on structure, pathogenicity and immunity aspects of pandemic human coronaviruses.从 SARS 到 SARS-CoV-2，了解大流行人类冠状病毒的结构、致病性和免疫方面的见解。
Infect Genet Evol. 2020 Nov;85:104502. doi: 10.1016/j.meegid.2020.104502. Epub 2020 Aug 13.
本文引用的文献
1
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.严重急性呼吸综合征冠状病毒 2 型（SARS-CoV-2）进入细胞依赖于 ACE2 和 TMPRSS2，可被一种临床验证的蛋白酶抑制剂所阻断。
Cell. 2020 Apr 16;181(2):271-280.e8. doi: 10.1016/j.cell.2020.02.052. Epub 2020 Mar 5.
2
Epidemiological characteristics of SARS-CoV-2 infections in Shaanxi, China by 8 February 2020.截至 2020 年 2 月 8 日中国陕西地区 SARS-CoV-2 感染的流行病学特征。
Eur Respir J. 2020 Apr 23;55(4). doi: 10.1183/13993003.00310-2020. Print 2020 Apr.
3
Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses.SARS-CoV-2 及其他 B 属β冠状病毒的细胞进入和受体使用功能评估。
Nat Microbiol. 2020 Apr;5(4):562-569. doi: 10.1038/s41564-020-0688-y. Epub 2020 Feb 24.
4
Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation.2019 年新型冠状病毒刺突蛋白在预融合构象的冷冻电镜结构
Science. 2020 Mar 13;367(6483):1260-1263. doi: 10.1126/science.abb2507. Epub 2020 Feb 19.
5
A novel coronavirus outbreak of global health concern.一场引发全球卫生关注的新型冠状病毒疫情。
Lancet. 2020 Feb 15;395(10223):470-473. doi: 10.1016/S0140-6736(20)30185-9. Epub 2020 Jan 24.
6
Suppression of lung inflammation by the ethanol extract of Chung-Sang and the possible role of Nrf2.钟桑乙醇提取物对肺部炎症的抑制作用及其对 Nrf2 的可能作用。
BMC Complement Altern Med. 2019 Jan 10;19(1):15. doi: 10.1186/s12906-018-2422-3.
7
Anti-inflammatory activity of the decoction of Forsythia suspensa (Thunb.) Vahl is related to Nrf2 and A20.连翘汤的抗炎活性与 Nrf2 和 A20 有关。
J Ethnopharmacol. 2018 Dec 5;227:97-104. doi: 10.1016/j.jep.2018.08.027. Epub 2018 Aug 24.
8
Korean medicine coverage in the National Health Insurance in Korea: present situation and critical issues.韩国国民健康保险中的韩医学覆盖情况：现状与关键问题
Integr Med Res. 2013 Sep;2(3):81-88. doi: 10.1016/j.imr.2013.06.004. Epub 2013 Jul 3.
9
Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology.致病性人类冠状病毒感染：细胞因子风暴和免疫病理学的成因及后果
Semin Immunopathol. 2017 Jul;39(5):529-539. doi: 10.1007/s00281-017-0629-x. Epub 2017 May 2.
10
Middle East Respiratory Syndrome: Emergence of a Pathogenic Human Coronavirus.中东呼吸综合征：一种致病性人类冠状病毒的出现。
Annu Rev Med. 2017 Jan 14;68:387-399. doi: 10.1146/annurev-med-051215-031152. Epub 2016 Aug 26.
Zotero 插件